The Patent Finder

Terms ending in 2032

CureVac AG

Every in-force patent on CureVac AG's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,447,431Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,111,968Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,166,283Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Pathogenic Antigen
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,610,605Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,912,826Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Pathogenic Antigen
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,172,935Vaccination in Newborns and Infants
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 10,596,252Vaccination in Newborns and Infants
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 10,729,761Vaccination in Newborns and Infants
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 11,672,856Vaccination in Newborns and Infants
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,975,064VACCINATION WITH mRNA-CODED ANTIGENS
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
9 more term ends in 2032 · Pro
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited